Kerstin Stein

862 total citations
19 papers, 502 citations indexed

About

Kerstin Stein is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Kerstin Stein has authored 19 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 15 papers in Hepatology and 2 papers in Infectious Diseases. Recurrent topics in Kerstin Stein's work include Hepatitis C virus research (12 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis B Virus Studies (7 papers). Kerstin Stein is often cited by papers focused on Hepatitis C virus research (12 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis B Virus Studies (7 papers). Kerstin Stein collaborates with scholars based in Germany, United Kingdom and United States. Kerstin Stein's co-authors include Thomas Berg, Peter Buggisch, Ulrich Spengler, Robert A. de Man, Andreas Erhardt, Heiner Wedemeyer, Bertram Wiedenmann, Bernd Möller, Florian van Bömmel and Jörg Trojan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

Kerstin Stein

15 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kerstin Stein Germany	7	410	363	97	85	23	19	502
Maria Lúcia Alves Pedroso Brazil	11	175 0.4×	135 0.4×	37 0.4×	65 0.8×	6 0.3×	22	296
Khozema B. Hussain United States	9	463 1.1×	480 1.3×	21 0.2×	8 0.1×	14 0.6×	11	609
F. Bianic France	11	188 0.5×	77 0.2×	28 0.3×	16 0.2×	7 0.3×	31	314
Susana Llerena Spain	12	338 0.8×	304 0.8×	39 0.4×	13 0.2×	14 0.6×	36	473
Dragan Delić Serbia	11	274 0.7×	257 0.7×	39 0.4×	3 0.0×	10 0.4×	46	351
Amy Puenpatom United States	10	158 0.4×	162 0.4×	118 1.2×	6 0.1×	15 0.7×	39	299
Damaris Carriero United States	10	138 0.3×	156 0.4×	41 0.4×	40 0.5×	27 1.2×	13	310
Shimaa Afify Egypt	10	170 0.4×	147 0.4×	75 0.8×	13 0.2×	11 0.5×	33	314
Carmen Díaz Spain	10	325 0.8×	310 0.9×	19 0.2×	7 0.1×	24 1.0×	17	450

Countries citing papers authored by Kerstin Stein

Since Specialization

Citations

This map shows the geographic impact of Kerstin Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerstin Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerstin Stein more than expected).

Fields of papers citing papers by Kerstin Stein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerstin Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerstin Stein. The network helps show where Kerstin Stein may publish in the future.

Co-authorship network of co-authors of Kerstin Stein

This figure shows the co-authorship network connecting the top 25 collaborators of Kerstin Stein. A scholar is included among the top collaborators of Kerstin Stein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerstin Stein. Kerstin Stein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Petroff, David, Jörn M. Schattenberg, S Zeuzem, et al.. (2025). Evaluating Resmetirom Eligibility Among Patients with MASH: Insights from the German Steatotic Liver Disease-Registry. Zeitschrift für Gastroenterologie. 63(8). 836–843. 1 indexed citations

Geier, Andreas, Monika Rau, Anita Pathil‐Warth, et al.. (2023). Clinical characteristics of patients with non-alcoholic fatty liver disease (NAFLD) in Germany – First data from the German NAFLD-Registry. Zeitschrift für Gastroenterologie. 61(1). 60–70. 4 indexed citations

Hofmann, Wolf Peter, Peter Buggisch, Lisa Schubert, et al.. (2020). The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care. JHEP Reports. 2(6). 100168–100168. 14 indexed citations

Stein, Kerstin, Albrecht Stoehr, Hartwig Klinker, et al.. (2020). Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease: data from the German Hepatitis C-Registry (DHC-R). European Journal of Gastroenterology & Hepatology. 34(1). 76–83. 6 indexed citations

Berg, Thomas, Peter Buggisch, D. Hueppe, et al.. (2019). Real-Life Experiences with Telaprevir in the Treatment of Chronic Genotype 1 Hepatitis C — The TEPS Study. SHILAP Revista de lepidopterología. 28(6). 15–26.

Hofmann, Wolf Peter, Nektarios Dikopoulos, Frank Lammert, et al.. (2019). SAT-348-Low frequencies of lifestyle interventions and liver-specific medications in a multicentric prospective real world NAFLD cohort: The fatty liver assessment in Germany (FLAG) study. Journal of Hepatology. 70(1). e792–e792.

Schattenberg, Jörn M., Lisa Schubert, Nektarios Dikopoulos, et al.. (2019). Baseline patient characteristics of the German multicentric prospective real-world NAFLD cohort: The Fatty Liver Assessment in Germany (FLAG) study. Zeitschrift für Gastroenterologie.

Stein, Kerstin, et al.. (2018). Predictors of functional benefit of hepatitis C therapy in a ‘real-life’ cohort. World Journal of Gastroenterology. 24(7). 852–861. 2 indexed citations

Wex, Thomas, Kerstin Stein, Cosima Langner, et al.. (2018). Helicobacter Pylori Serology in Relation to Hepatitis C Virus Infection and IL28B Single Nucleotide Polymorphism. Journal of Clinical Medicine. 7(3). 44–44. 4 indexed citations

10.

Schiefke, Ingolf, et al.. (2016). Interferon-free treatment of chronic hepatitis C virus infection in patients with inherited bleeding disorders. Hämostaseologie. 37(2). 127–130. 8 indexed citations

11.

Sprinzl, Martin F., Tim Zimmermann, Marcus A. Wörns, et al.. (2015). Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort. BMC Gastroenterology. 15(1). 97–97. 16 indexed citations

12.

Schreiber, Jens, et al.. (2014). Occult interferon α-induced pulmonary granulomatosis despite continuation of treatment. International Journal of Clinical Pharmacology and Therapeutics. 52(11). 1012–1016. 1 indexed citations

13.

Wyatt, Katrina, William Henley, Lindsey Anderson, et al.. (2012). The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders.. Health Technology Assessment. 16(39). 1–543. 102 indexed citations

14.

Stein, Kerstin, S Rickes, Marino Venerito, & Peter Malfertheiner. (2012). Erste Daten zur Hepatitis C-Prävalenz in Mitteldeutschland: Vergleich von Großstadt und ländlicher Region. Zeitschrift für Gastroenterologie. 50(8).

15.

Bömmel, Florian van, Robert A. de Man, Heiner Wedemeyer, et al.. (2009). Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide Analogues. Hepatology. 51(1). 73–80. 264 indexed citations

16.

Man, Robert A. de, Kerstin Stein, J. Petersen, et al.. (2008). 73 A MULTICENTER ANALYSIS OF ANTIVIRAL RESPONSE AFTER ONE YEAR OF TENOFOVIR MONO-THERAPY IN HBV-MONOINFECTED PATIENTS WITH PRIOR NUCLEOS(T)IDE ANALOG EXPERIENCE. Journal of Hepatology. 48. S32–S32. 18 indexed citations

17.

Bömmel, Florian van, Robert A. de Man, Kerstin Stein, et al.. (2008). 381 A Multicenter Analysis of Antiviral Response After One Year of Tenofovir Mono-Therapy in HBV-Monoinfected Patients with Prior Nucleos(t)ide Analog Experience. Gastroenterology. 134(4). A–51. 1 indexed citations

18.

Kallinowski, B., Kerstin Stein, Tobias Goeser, et al.. (2007). [604] COMPARISON OF A SHORTENED RIBAVIRIN TREATMENT VS A 24 WEEK STANDARD COMBINATION THERAPY IN HCV INFECTED PATIENTS WITH GENOTYPE 2/3. Journal of Hepatology. 46. S228–S229. 2 indexed citations

19.

Castelnuovo, E, Jo Thompson Coon, Martin Pitt, et al.. (2006). The cost-effectiveness of testing for hepatitis C in former injecting drug users. Health Technology Assessment. 10(32). iii–iv, ix. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact